Correlation Between Okta and Myriad Genetics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Okta and Myriad Genetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Okta and Myriad Genetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Okta Inc and Myriad Genetics, you can compare the effects of market volatilities on Okta and Myriad Genetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Okta with a short position of Myriad Genetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Okta and Myriad Genetics.

Diversification Opportunities for Okta and Myriad Genetics

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between Okta and Myriad is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Okta Inc and Myriad Genetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Myriad Genetics and Okta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Okta Inc are associated (or correlated) with Myriad Genetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Myriad Genetics has no effect on the direction of Okta i.e., Okta and Myriad Genetics go up and down completely randomly.

Pair Corralation between Okta and Myriad Genetics

Given the investment horizon of 90 days Okta Inc is not expected to generate positive returns. However, Okta Inc is 1.17 times less risky than Myriad Genetics. It waists most of its returns potential to compensate for thr risk taken. Myriad Genetics is generating about -0.03 per unit of risk. If you would invest  8,265  in Okta Inc on August 28, 2024 and sell it today you would lose (615.00) from holding Okta Inc or give up 7.44% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Okta Inc  vs.  Myriad Genetics

 Performance 
       Timeline  
Okta Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Okta Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Myriad Genetics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Myriad Genetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Okta and Myriad Genetics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Okta and Myriad Genetics

The main advantage of trading using opposite Okta and Myriad Genetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Okta position performs unexpectedly, Myriad Genetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Myriad Genetics will offset losses from the drop in Myriad Genetics' long position.
The idea behind Okta Inc and Myriad Genetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital